Somerville Kurt F Makes New $8.34 Million Investment in Proto Labs, Inc. $PRLB

Somerville Kurt F purchased a new position in shares of Proto Labs, Inc. (NYSE:PRLBFree Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 91,953 shares of the industrial products company’s stock, valued at approximately $8,344,000. Proto Labs comprises approximately 2.0% of Somerville Kurt F’s holdings, making the stock its 20th biggest holding. Somerville Kurt F owned about 0.38% of Proto Labs as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of PRLB. Royal Bank of Canada increased its position in Proto Labs by 51.3% during the first quarter. Royal Bank of Canada now owns 6,510 shares of the industrial products company’s stock worth $228,000 after acquiring an additional 2,207 shares during the period. AQR Capital Management LLC boosted its holdings in Proto Labs by 3.3% in the 1st quarter. AQR Capital Management LLC now owns 63,871 shares of the industrial products company’s stock valued at $2,238,000 after purchasing an additional 2,040 shares during the period. NewEdge Advisors LLC grew its position in Proto Labs by 7,380.0% in the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after purchasing an additional 738 shares during the last quarter. JPMorgan Chase & Co. grew its position in Proto Labs by 68.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 21,756 shares of the industrial products company’s stock worth $871,000 after purchasing an additional 8,864 shares during the last quarter. Finally, Hsbc Holdings PLC acquired a new stake in Proto Labs in the 2nd quarter worth $480,000. 84.54% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Sven Wehrwein sold 2,000 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total value of $154,560.00. Following the sale, the director owned 32,505 shares of the company’s stock, valued at $2,511,986.40. The trade was a 5.80% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

Proto Labs Stock Down 3.3%

NYSE PRLB opened at $82.11 on Thursday. Proto Labs, Inc. has a twelve month low of $45.10 and a twelve month high of $93.00. The stock has a market cap of $1.96 billion, a P/E ratio of 65.69 and a beta of 1.40. The company’s 50-day simple moving average is $80.53 and its 200 day simple moving average is $69.94.

Proto Labs (NYSE:PRLBGet Free Report) last announced its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The firm had revenue of $149.34 million during the quarter, compared to analysts’ expectations of $144.53 million. During the same quarter last year, the company earned $0.41 earnings per share. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. Research analysts anticipate that Proto Labs, Inc. will post 1.46 earnings per share for the current year.

Wall Street Analyst Weigh In

PRLB has been the subject of a number of research analyst reports. Weiss Ratings lowered shares of Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday. Benchmark lifted their target price on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 18th. Zacks Research upgraded Proto Labs from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 6th. Finally, Needham & Company LLC raised Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 price objective on the stock in a report on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the company’s stock. According to data from MarketBeat, Proto Labs has an average rating of “Buy” and an average price target of $89.00.

Read Our Latest Report on Proto Labs

Proto Labs Profile

(Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

See Also

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.